Literature DB >> 16086734

Toxic epidermal necrolysis: current evidence, practical management and future directions.

T A Chave1, N J Mortimer, M J Sladden, A P Hall, P E Hutchinson.   

Abstract

Toxic epidermal necrolysis (TEN) is a rare disorder characterized by extensive epidermal death. Almost all cases appear to be caused by an idiosyncratic drug reaction. Proposed pathogenic mechanisms are conflicting, and the evidence for the benefits of individual treatments is inadequate, and in some cases contradictory. The mortality rate remains high. We review the literature pertaining to the pathogenesis of TEN and drug reactions in general. The rationale for therapeutic interventions, together with reported evidence of efficacy, are considered. We present a composite model of TEN, based on previous work and suggested pathogeneses of TEN, mechanisms of drug reactions and reported cytotoxic lymphocyte (CTL) cytolytic pathways. In this system, TEN, like some other cutaneous drug eruptions, is an HLA class I-restricted, specific drug sensitivity, resulting in clonal expansion of CD8+ CTLs. Cytotoxicity is mediated by CTL granzyme and possibly death receptor (DR) ligand (DR-L), probably Fas ligand (FasL). Particular to TEN, there is then an amplification sequence involving further DR-L expression. FasL is likely to be particularly important but tumour necrosis factor (TNF) may well contribute, via the TNF receptor 1 (TNF-R1) death pathway. Alternatively, we suggest the possibility of upregulation of an antiapoptotic TNF-R1-nuclear factor kappaB pathway, which would proscribe treatments which downregulate this pathway. None of the published data on individual treatment efficacies is sufficiently strong to suggest a definitive single treatment. Currently a multifaceted regimen appears indicated, targeting various likely intermediary mechanisms, including elimination of residual drug, immunosuppression, inhibition of DR pathways, general antiapoptotic strategies, and aggressive supportive care. Particular attention has been directed at avoiding potential conflicts between different treatments and avoiding agents that theoretically might have a net proapoptotic rather than antiapoptotic effect. Nursing on a specialized unit is of paramount importance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16086734     DOI: 10.1111/j.1365-2133.2005.06721.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  39 in total

Review 1.  Toxic Epidermal Necrolysis and Steven-Johnson Syndrome: A Comprehensive Review.

Authors:  Olivia A Charlton; Victoria Harris; Kevin Phan; Erin Mewton; Chris Jackson; Alan Cooper
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-01-09       Impact factor: 4.730

2.  [Toxic epidermal necrolysis].

Authors:  V Lewerenz; D Bruch-Gerharz; T Ruzicka; R Kruse
Journal:  Hautarzt       Date:  2006-04       Impact factor: 0.751

3.  Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England.

Authors:  Deborah Layton; Vanessa Marshall; Andrew Boshier; Peter Friedmann; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 4.  Drug-hypersensitivity syndrome: diagnosis and treatment.

Authors:  Rose L Hamm
Journal:  J Am Coll Clin Wound Spec       Date:  2012-06-23

Review 5.  Skin manifestations of drug allergy.

Authors:  Michael R Ardern-Jones; Peter S Friedmann
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

Review 6.  Severe cutaneous adverse drug reactions.

Authors:  Rajesh Verma; Biju Vasudevan; Vijendran Pragasam
Journal:  Med J Armed Forces India       Date:  2013-03-17

Review 7.  Paraneoplastic pemphigus in a burn intensive care unit: case report and review of the literature.

Authors:  Awori J Hayanga; Timothy M Lee; Christopher J Pannucci; Brian S Knipp; Stephen H Olsen; Stewart C Wang; Lena M Napolitano
Journal:  J Burn Care Res       Date:  2010 Sep-Oct       Impact factor: 1.845

8.  Update on the management of antibiotic allergy.

Authors:  Bernard Yu-Hor Thong
Journal:  Allergy Asthma Immunol Res       Date:  2010-03-24       Impact factor: 5.764

Review 9.  Amniotic membrane transplantation as a new therapy for the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Elizabeth Shay; Ahmad Kheirkhah; Lingyi Liang; Hossam Sheha; Darren G Gregory; Scheffer C G Tseng
Journal:  Surv Ophthalmol       Date:  2009-08-21       Impact factor: 6.048

10.  Toxic epidermal necrolysis following treatment of pseudotumour cerebri: a case report.

Authors:  Mohamed El Ghonemi; Hesham R Omar; Rania Rashad; Jaya Kolla; Devanand Mangar; Enrico Camporesi
Journal:  Cases J       Date:  2009-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.